5Cohen P, Rogol A D, Deal C L, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endo- crine Society,and the European Society for Paediatric Endocrinology Workshop[J]. Clin Endoerinol Metab,2008,93 ( 11 ) : 4210-4217.
6Wit J M, Kiess W, Mullis P. Genetic evaluation of short stature [J]. Best Practice & Research Clinical Endocrinology & Metabolism, 2011,25 (1):1-17.
9David S, Millar, Mark D. Lewis, Martin Horana,et al. Growth hormone (GH1) gene variation and the growth hormone receptor ( GHR ) exon 3 deletion polymorphism in a West- African population [J]. Molecular and Cellular Endocrinology, 2008,296 ( 1 - 2) : 18-25.
10Camilla A M, Johannsson G G, Carlsson L M S, et al. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full- length polymorphism using a tagSNP [J]. Growth Hormone & IGF Research, 2010,20 (3) : 270-273.
5Rosenfeld,RG.The molecular basis of idiopathic short stature.Growth Hormone and IGF Research,2005,15(Suppl A):S3-S5.
6Rappald GA,Fukami M,Niesler B,et al.Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.J Clin Endocrinol Metab,2002,87:1402-1406.
7Toyoshima MT,Castroneves LA,Costalonga EF,et al.Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.Clin Endoorinol,2007,67:500-504.
8Kamp CA,Mul D,Waelkens J J,et al.A randomized controlled trial of three years growth hormone and gonedotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.J Clin Endocrinol Metab,2001,86:2969-2975.
9Hero M,Makitie O,Kroger H,et al.Impact of aromatase inhibitor therapy on bone turnover,cortical bone growth and vertebral morpholngy in pre-and peripubertal boys with idiopathic short stature.Horm Res,2009,71:290-297.
10Rosenhloom AL.The role of recombinant insulin-like growth factar 1 in the treatment of the short child.Curr Opin Pediatri,2007,19:458-464.
